top of page

C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech

Updated: Jul 2, 2023

C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech. This episode is brought to you by the new Higher Learning LV Core Cannabis course. Learn the 25 most important cannabinoids and eight most common terpenes for an affordable enrollment fee of only $240.


To learn more about the topic of bioavailability, see our article Understanding Cannabis Bioavailability.

 

C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech

In No. 48 of the Cannabis Commerce + Chemistry Podcast, host Curt Robbins gives co-hosts Dena Putnam and John Bailey the week off to go one-on-one with Dr. Charles Johnson from Ally Biotech in Arizona.


Dr. Charles Johnson, Francis Baczek, and Jim Mackowiak
Dr. Charles Johnson, Francis Baczek, and Jim Mackowiak from Ally Biotech

C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech. "Johnson, better known as Dr. Chuck, heads a pioneering biotech company, Ally Biotech, that is harnessing science to produce breakthrough THC products that have a profoundly positive impact on humanity," said Robbins.


C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech

Robbins and Dr. Johnson get nerdy and dive into the biochemical nuances of cannabis medicine and, in particular, nanoemulsion technology and how cannabinoids and terpenes produced by marijuana are fat-loving, water-fearing molecules that are not easily integrated into water-based beverages. They discuss critical characteristics of cannabis medicine, including bioavailability.


"While watching my father suffer from rheumatoid arthritis and the less than effective conventional medical care that he received, I resolved myself to find a better way. This emerging industry has provided me the opportunity to thrive in the pursuit of that better way," said Johnson. This progressive scientist discusses the intersection between cannabis medicine and pharmaceutical therapies in conventional medicine.

Ally Biotech is pioneering the next generation of cannabis products.
Ally Biotech is pioneering the next generation of cannabis products.

"It simply is a philosophical problem. And that is: Let's treat the symptom, not treat the root cause," said Johnson. "If you think about autoimmune disorders...I philosophically disagree with putting a biologic in play that we can minimize the effectiveness of your immune system so that you're feeling a little bit better.


"Dr. Chuck described the team at Ally Biotech and their passion for helping cannabis patients gain true efficacy from medicine that offers them better relief from issues such as pain, inflammation, and other negative symptoms of diseases such as autoimmune disorders.

The Cannabis Commerce + Chemistry Podcast logo
All business. No small talk.

This weekly podcast is targeted at cannabis and hemp industry professionals and is strategically free of profanity and crude dialog. This audio session was edited for length and clarity.

Listen now at Higher Learning LV, on Apple Podcasts or Spotify, and most other major podcasting platforms (including Amazon Music, Anchor, Google Podcasts, iHeart Radio, Pandora, and Stitcher).


🎧 C3 No. 48: Dr. Charles Johnson from Ally Biotech Show Notes⁠

The Higher Learning LV text logo.

Did you enjoy C3 Podcast No. 48: Dr. Charles Johnson from Ally Biotech? Are you a cannabis industry professional? Check out Higher Learning LV's Deep Dive Subscription that features dozens of long-form articles based on the latest peer-reviewed scientific research. Priced to accommodate personal and enterprise training budgets.

Recent Posts

See All

Comentarios


bottom of page